Skip to main content

Market Overview

Vetr Top Raters Upgrade Bristol-Myers Squibb, Over 80% Bullish

Share:

Shares of Bristol-Myers Squibb Co (NYSE: BMY) have lost more than 10 percent since the start of 2016 and are nearly flat over the past year.

A lack of growth in Bristol-Myers' stock over the past year hasn't deterred the Vetr crowd. The crowd-sourced stock rating platform upgraded the stock's rating to 4.5-stars out of a possible 5-stars. In fact, shares have risen to $61.71 since the prior rating of 4.0-stars was issued 14 days ago.

Related link: Here's how crowdsourced ratings can beat the market.

In addition to an upgrade to bull territory, 83 percent of the crowd's ratings are bullish and the crowd sourced price target of $69.74 implies a potential upside of nearly 14 percent.

Héctor Garcia, a member of the Vetr crowd, commented 10 days ago that Bristol-Myers' stock is trading below its 50 and 200-day moving average. The crowd member added that while this may be a bullish signal, the current market condition for healthcare stocks is "less than favorable." As such, Bristol-Myers' stock is more appropriate for a longer-term investor that can stomach near-term volatility.

Latest Ratings for BMY

DateFirmActionFromTo
Mar 2022Wells FargoMaintainsEqual-Weight
Dec 2021Goldman SachsInitiates Coverage OnBuy
Dec 2021Wells FargoInitiates Coverage OnEqual-Weight

View More Analyst Ratings for BMY

View the Latest Analyst Ratings

 

Related Articles (BMY)

View Comments and Join the Discussion!

Posted-In: Crowd Sourced Stock RatingsAnalyst Color Biotech Long Ideas Crowdsourcing Analyst Ratings Trading Ideas General

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com